Compass Labs offer a test for HPV
Author: Katherine Pfaff
Compass Laboratory Services has developed an oral rinse to detect high-risk HPV in the oral cavity, OraGen HPV. The human papillomavirus (HPV) is linked to neck and head cancers. More than 25 million Americans are thought to have HPV. Specific subtypes of HPV are thought to increase cancer risk, making detection important.
OraGen HPV genotyping test is intended to detect strains of high-risk HPV. The test can detect HPV 16/18, which is thought to pose the greatest risk for developing head and neck cancer.
For info contact:
Compass Lab Services
Phone: 901.348.5774
Email: info@compasslabservices.com
Source: www.compasslabservices.com
Image credit: Compass Laboratory Services
Related articles
Products 05 November 2025
SimplyTest has launched a groundbreaking saliva-based test to detect high-risk strains of oral human papillomavirus (HPV), a major cause of oropharyngeal cancers.
Read more
Products 24 June 2026
News 24 June 2026
The program celebrates graduates joining the nationwide Aspen Dental network in a landscape of growing demand for oral healthcare professionals.
News 24 June 2026
Mitsui Chemicals recently announced its intention to acquire Ultradent Products Inc., a global leader in cosmetic, preventive, and restorative dentistry.
Editorials 24 June 2026
Personal trauma leads to dental hygiene career for new Texas A&M College of Dentistry honor grad
Endodontics 24 June 2026
This peer-reviewed endodontics article summarizes clinical evidence from BMC oral health (2026). It focuses on findings that may help dental professionals evaluate treatment decisions, patient...
Copyright © 2026 - All Rights Reserved
ISSN 2767-1178